ChengDa Pharmaceuticals Co. Ltd. Tangible Net Worth Ratio
ChengDa Pharmaceuticals Co. Ltd. tangible net worth ratio. ChengDa Pharmaceuticals Co. Ltd. (301201) has a Tangible Net Worth Ratio of 98.2% as of June 2026. This metric is calculated by deducting intangible assets (CN¥36.88 Million) from net assets (CN¥2.10 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore how fast is ChengDa Pharmaceuticals Co. Ltd. growing its equity to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of ChengDa Pharmaceuticals Co. Ltd. (2019–2025)
Tangible net worth ratio of ChengDa Pharmaceuticals Co. Ltd. from 2019 to 2025. This chart shows how ChengDa Pharmaceuticals Co. Ltd.'s Tangible Net Worth Ratio has changed across 7 annual periods from 2019 to 2025. As of June 2026, the ratio stands at 98.2%, reflecting net assets of CN¥2.10 Billion with intangible assets of CN¥36.88 Million CNY.
ChengDa Pharmaceuticals Co. Ltd. Tangible Net Worth Ratio by Year (2019–2025)
ChengDa Pharmaceuticals Co. Ltd. tangible net worth ratio by year from 2019 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for ChengDa Pharmaceuticals Co. Ltd. from 2019 to 2025, covering 7 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see 301201 market cap.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 98.2% | CN¥2.10 Billion | CN¥37.16 Million | CN¥2.35 Billion | ▼ -0.1 pp |
| 2024 | 98.3% | CN¥2.15 Billion | CN¥36.51 Million | CN¥2.44 Billion | ▼ -0.2 pp |
| 2023 | 98.5% | CN¥2.28 Billion | CN¥33.85 Million | CN¥2.46 Billion | ▲ +0.1 pp |
| 2022 | 98.4% | CN¥2.22 Billion | CN¥34.58 Million | CN¥2.32 Billion | ▲ +6.0 pp |
| 2021 | 92.5% | CN¥529.93 Million | CN¥39.83 Million | CN¥683.23 Million | ▲ +1.4 pp |
| 2020 | 91.1% | CN¥458.91 Million | CN¥41.05 Million | CN¥534.21 Million | ▼ -4.1 pp |
| 2019 | 95.1% | CN¥357.35 Million | CN¥17.49 Million | CN¥546.56 Million | — |